OR WAIT null SECS
August 01, 2013
External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ingredients and intermediates.
July 02, 2013
Claudia Roth, President of Vetter Development Service USA, discusses trends in single-use technology for clinical manufacturing.
The US and EU move forward with measures to fortify the pharmaceutical supply chain.
March 02, 2013
As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments.
February 01, 2013
When speaking of partnerships, the discussion typically focuses on the relationship between a pharmaceutical/biopharmaceutical company as the sponsor company and a contract-service provider.
October 31, 2012
Patheon will acquire softgel-specialist company Banner Pharmacaps, based in North Carolina in the US, for $255 million
August 01, 2012
The author provides results and commentary on a survey analyzing outsourcing strategies, practices, challenges, and outcomes in the selection of a CRO.
The author discusses how a CDMO helps in gaining process understanding and in developing robust, high-quality products and processes.
July 02, 2012
Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.